Cargando…

1166: IN-PATIENT ANTIBIOTIC EXPOSURE PROMOTES SARS-COV-2 PERSISTENCE IN THE GI TRACT IN COVID-19 ADMITTED PATIENTS

Detalles Bibliográficos
Autores principales:	Sharma, Ashok, Martin, Anthony, Moskowitz, Jacob E., Bora, Stephanie, Legree, Katherine, Dorrestein, Pieter, Underhill, David, Knight, Rob, Chen, Peter, Devkota, Suzanne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AGA Institute. Published by Elsevier Inc. 2022
Materias:	AGA Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212536/ http://dx.doi.org/10.1016/S0016-5085(22)60660-7

Ejemplares similares

Sa1063: COVID AND COVID VACCINATION AMONG OUTPATIENTS WITH FUNCTIONAL GI AND GI MOTILITY DISORDERS; EFFECTS ON GI SYMPTOMS.
por: Silver, Paul, et al.
Publicado: (2022)

Fr093 COVID-19 PEDIATRIC PATIENTS IN THE UNITED STATES; AFRICAN AMERICAN AND HISPANIC AMONG MOST HOSPITALIZED PATIENTS WITH PERSISTENT GI MANIFESTATIONS
por: Ashktorab, Yusuf, et al.
Publicado: (2021)

Fr095 AN ANALYSIS OF GI AND NON-GI MANIFESTATIONS OF COVID-19 DURING THE FIRST WAVE OF THE PANDEMIC IN DARLINGTON, UNITED KINGDOM
por: Dhar, Anjan, et al.
Publicado: (2021)

Su1067: LIVER ENZYMES ALTERATION BUT NOT GI SYMPTOMS ARE ASSOCIATED WITH DEATH IN MINORITY COVID-19 PATIENTS WITH CANCER
por: Oskrochi, Gholamreza, et al.
Publicado: (2022)

Sa081 FEAR OF COVID-19 AMONG IBD PATIENTS ACCORDING TO EMPLOYMENT STATUS, EDUCATION AND RESIDENCE AND COMPARED TO OTHER GI CONDITIONS
por: Lo, Bobby, et al.
Publicado: (2021)

Fr005 SEVERE COVID-19 ASSOCIATED WITH INCREASED RISK OF GI BLEEDING DURING HOSPITALIZATION
por: Alvencar, Sujay, et al.
Publicado: (2021)

EP1019: THE EFFECTS OF THE COVID-19 PANDEMIC ON PRESENTATIONS AND DIAGNOSIS OF UPPER GI AND HEPATOPANCREATICOBILIARY MALIGNANCIES
por: Carroll, Andrew, et al.
Publicado: (2022)

Sa110 IMPACT OF COVID-19 PANDEMIC ON THE MANAGEMENT AND CLINICAL OUTCOMES OF PATIENTS ADMITTED WITH UPPER GASTROINTESTINAL BLEEDING
por: Manomaiwong, Ekawat, et al.
Publicado: (2021)

Fr091 WHY AREN'T WE USING TELEMEDICINE MORE? A COMPARISON OF TELEMEDICINE USAGE ACROSS GI AND CANCER CLINICS DURING THE COVID-19 PANDEMIC
por: Peter, Shajan, et al.
Publicado: (2021)

1161: PERSISTENT IMMUNE CELL ABNORMALITIES IN THE INTESTINAL MUCOSA OF PATIENTS AFTER RECOVERY FROM COVID-19 INFECTION
por: Meringer, Hadar, et al.
Publicado: (2022)

426 DETECTION OF SARS-COV-2 IN THE GASTROINTESTINAL TRACT AMONG PATIENTS WITH NEGATIVE NASOPHARYNGEAL COVID-19 TESTING PRIOR TO ENDOSCOPY: A PROSPECTIVE STUDY
por: Yang, Dennis, et al.
Publicado: (2021)

782 PERSISTENT GASTROINTESTINAL SYMPTOMS AND CHRONIC FATIGUE AFTER SARS-COV-2 INFECTION.
por: Noviello, Daniele, et al.
Publicado: (2021)

Su083 PERSISTENCE OF GASTROINTESTINAL SYMPTOMS AFTER HOSPITALIZATION FOR COVID-19: PREVALENCE AND RISK FACTORS
por: Blackett, John W., et al.
Publicado: (2021)

Su1496: SARS-COV-2 INFECTION IN IBD: PANDEMIC WAVES AND PREDICTORS OF SEVERE OR PERSISTENT COVID-19
por: Taxonera, Carlos, et al.
Publicado: (2022)

785 SARS-COV-2 INFECTS ENTEROCYTES IN VIVO AND CAN PERSIST UP TO 7 MONTHS FOLLOWING RESOLUTION OF SYMPTOMS
por: Tokuyama, Minami, et al.
Publicado: (2021)

651: SARS-COV-2 IS DETECTED IN THE GASTROINTESTINAL TRACT OF ASYMPTOMATIC OUTPATIENTS USING ROUTINE ENDOSCOPY BUT POSES MINIMAL TRANSMISSION RISK
por: Gentry, Andrew B., et al.
Publicado: (2022)

Sa1050: COVID-19 VACCINATION RATES AND POST-VACCINATION INFECTION RISK IN IBD PATIENTS TREATED WITH DISEASE MODIFYING AGENTS: A RESEARCH NETWORK ANALYSIS
por: Chumbe, Julton Tomanguillo, et al.
Publicado: (2022)

Tu1553: SPECIFIC IMMUNOGLOBLIN A INDUCED BY THE PERSISTENT COLONIZATION OF ADHERENT-INVASIVE E.COLI LIMITS PATHOBINT LOCALIZATION TO THE EPITHELIAL NICHE
por: Imai, Jin, et al.
Publicado: (2022)

Fr508 TRANSITION TO HOME INFUSION FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE DURING CORONAVIRUS DISEASE 2019 PANDEMIC: PATIENT SATISFACTION SURVEY
por: Pasam, Ravi Teja, et al.
Publicado: (2021)

Fr105 CONTINUITY OF CARE FOR PATIENTS WITH CHRONIC GASTROINTESTINAL DISEASE: A LATENT CLASS ANALYSIS OF PATIENTS WITH HIGH-INTENSITY SPECIALTY CARE NEEDS
por: Cohen-Mekelburg, Shirley, et al.
Publicado: (2021)

855 PATIENT-LED REMOTE INTRACAPILLARY PHARMACOKINETIC SAMPLING (FINGERPRICKS): VALIDATION AND ACCEPTABILITY FOR HOME THERAPEUTIC DRUG MONITORING IN PATIENTS WITH IBD IN THE COVID-19 PANDEMIC
por: Chee, Desmond, et al.
Publicado: (2021)

Fr098 IMPACT OF COVID-19 PANDEMIC IN IBD PATIENT CARE
por: Dahiya, Monica, et al.
Publicado: (2021)

Fr492 SIGNIFICANTLY REDUCED MORTALITY IN COVID-19 PATIENTS WITH GASTROINTESTINAL MANIFESTATIONS
por: Livanos, Alexandra E., et al.
Publicado: (2021)

Fr501 BIOLOGICS AND COVID-19 OUTCOMES IN INFLAMMATORY BOWEL DISEASE PATIENTS
por: Weissman, Simcha, et al.
Publicado: (2021)

Fr576 ORAL BACTERIOTHERAPY IN PATIENTS WITH COVID-19: A RETROSPECTIVE COHORT STUDY
por: Marazzato, Massimiliano, et al.
Publicado: (2021)

Fr006 IMPACT OF A SARS-COV2 INFECTION IN PATIENTS WITH CELIAC DISEASE
por: Elli, Luca, et al.
Publicado: (2021)

Fr137 FIRST HIGH DIMENSIONAL EXAMINATION OF INTESTINAL BIOPSIES IN PATIENTS WITH COVID-19
por: Jha, Divya, et al.
Publicado: (2021)

EP1270: SEROCONVERSION IN INFLAMMATORY BOWEL DISEASE PATIENTS AFTER COVID-19 VACCINATION
por: Horvath, Miklos, et al.
Publicado: (2022)

Fr496 THE EFFECTS OF COMORBIDITIES ON COVID-19 OUTCOMES AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE
por: Parekh, Rajen, et al.
Publicado: (2021)

Fr500 COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: SYSTEMATIC REVIEW AND META-ANALYSIS
por: Tripathi, Kartikeya, et al.
Publicado: (2021)

113 COVID-19 PANDEMIC INCREASED HEALTHCARE UTILIZATION AMONG PATIENTS WITH FUNCTIONAL GASTROINTESTINAL DISORDERS
por: Gubatan, John Mark, et al.
Publicado: (2021)

Su1495: COVID-19 VACCINE HESITANCY REMAINS HIGH IN INFLAMMATORY BOWEL DISEASE PATIENTS
por: Kwon, Hyuk Joon, et al.
Publicado: (2022)

EP1018: GASTROINTESTINAL BLEEDING DURING THE COVID-19 PANDEMIC: IMPACT ON PATIENT PRESENTATION AND OUTCOMES
por: Kerbage, Anthony, et al.
Publicado: (2022)

Su1498: SAFETY OF COVID-19 VACCINATION IN INFLAMMATORY BOWEL DISEASE PATIENTS ON BIOLOGIC THERAPY
por: Garrido, Isabel, et al.
Publicado: (2022)

Sa1055: PERCEPTIONS OF ACCESSING CARE AMONG IBD PATIENTS DURING THE COVID-19 PANDEMIC
por: Shaffer, Seth R., et al.
Publicado: (2022)

Sa1685: OBESITY AND OUTCOMES IN YOUNG PATIENTS HOSPITALIZED FOR COLORECTAL CANCER IN THE US, 2016-2018
por: Wang, Yichen, et al.
Publicado: (2022)

329: BODY SURFACE GASTRIC MAPPING DEFINES NEUROMUSCULAR DYSFUNCTION IN PATIENTS WITH NAUSEA AND VOMITING SYNDROMES
por: Calder, Stefan S., et al.
Publicado: (2022)

Su1189 SAFETY OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH PREEXISTING INFLAMMATORY BOWEL DISEASE AND MICROSCOPIC COLITIS
por: Grover, Shilpa, et al.
Publicado: (2020)

Fr100 TELEMEDICINE IN GASTROENTEROLOGY: A STUDY ON FEASIBILITY AND PATIENTS’ TRUST DURING COVID-19 PANDEMIC.
por: Costantino, Andrea, et al.
Publicado: (2021)

Sa571 EVALUATION OF MENTAL STATE AND CLINICAL SYMPTOMS OF CORONAVIRUS PANDEMIC IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
por: Tani, Mizuki, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lpmnl120sqnlojm5tekm7fd0ia